PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 186 of 623

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

What Cannabis Manufacturers Can Learn from the Pharmaceutical Industry About Trace Metal Impurities in Plastic Materials

Cannabis Industry JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech (NASDAQ: EDSA) major holder's multi-million-share stake detailed

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength

FXEmpireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

New Jazz cancer drug approval could drive blockbuster sales

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health Care Up as Biotech Momentum Persists -- Health Care Roundup

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PDA becomes latest pharmacy body to publish AI guidance

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[New York Stock Market Highlights] Pharmaceutical stocks bought, AMD rises; sporting goods retailers plunge (25th)

MoomooOriginal source
🌍Industryallogene.comTier 1 · Company source

4: Statement of changes in beneficial ownership of securities

Allogene TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

La. challenge to mail-order abortion pills headed back to court

American PressOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Cells use a little-known molecule to protect themselves from iron overload

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Grants Inducement Restricted Stock Units to 23 New Employees

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Velan Capital lifts Edesa Biotech (EDSA) stake to 9.99% with warrant leverage

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?

simplywall.stOriginal source
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

Lunchbox labour is back — here’s how Canada’s new school food program can grow

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BMS Texas investment advances pharma’s modular manufacturing agenda

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Walter V. Klemp Discloses Investment at Moleculin Biotech with 9.87% Stake

TradingViewOriginal source
🌍Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adial PharmaceuticalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tracking ripubatide across three clinical registries

ClarivateOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

Bringing Science Full Circle: Ben Schooler Shares What Has Motivated His Path at BioMarin

BioMarin PharmaceuticalOriginal source
🌍Industrynews.intermountainhealth.orgTier 3 · Secondary coverage

Transplant Patients, Physicians, and Caregivers from Four Hospitals Celebrate UTAH Cardiac Transplant Program’s 40th Anniversary – A National Model of Collaboration

<![CDATA[Intermountain Health Newsroom]]>Original source
🇺🇸Industrybrukercellularanalysis.comTier 3 · Secondary coverage

Cell Line Development at an Inflection Point: Insights from BPI West and ESACT 2026

Berkeley LightsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Imaavy for wAIHA | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Ayub’s Fort Licence Over Serious Food Safety Violations, Kurla Canteen Also

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Recalls and Warnings: Levothyroxine and Natural Thyroid Drugs Recalled for Potency Problems

MedShadow FoundationOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

Once thriving, now threatened

University of California IrvineOriginal source
🌍Industrymyriad.comTier 3 · Secondary coverage

Beyond Eligibility: The Real Impact of the 2026 NCCN Genetic Testing Updates

MyriadOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Convertible bonds come back to bite Korean biotech firms as shares slump

KED GlobalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ayub's Food Licence Suspended by FDA: Pics Show Improper Egg Storage, Open Drains in Mumbai’s Famous

LatestLYOriginal source
🌍Industrydarebioscience.comTier 1 · Company source

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

Dare BioscienceOriginal source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

AI Isn’t a Stand-Alone Solution. Let’s Stop Treating It Like One.

SCRS (Clinical Research Sites)Original source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

Trained, but Not Prepared: The State of Clinical Research Site Training

SCRS (Clinical Research Sites)Original source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

How Better Research Site Support Improves Clinical Trial Delivery

SCRS (Clinical Research Sites)Original source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

Beyond the Database: Building Relationships That Drive Patient Recruitment

SCRS (Clinical Research Sites)Original source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

Closed Ticket, Open Problem: How Vendor Handoffs Keep Becoming Site Work

SCRS (Clinical Research Sites)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Fox NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cockroaches, Filth: Food Safety Crackdown At Posh Bengaluru Clubs

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Free fruit, toxic shock: Datura lands woman in hospital, sparks FDA action

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Boston Business Journal: Biotech jobs dropped for the first time in 2025. Can rebounding VC, M&A bring them back?

Massachusetts Biotechnology CouncilOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum

Barchart.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Where Connected Pharmacovigilance Is Headed Next

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum

openPR.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lady Gaga’s Fiancé Michael Polansky Has a Biotech Startup Involving AI & Living Skin

BillboardOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

CAP-1002（deramiocel）：BLA審査継続に伴うPDUFA dateの延長に関するお知らせ

Nippon Shinyaku NewsOriginal source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

76th WHO Regional Committee for Africa – A new era of health for Africa: United action for Vision 2035

IFPMA GlobalOriginal source
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

New UBC tool helps cities plant trees where they’re needed most

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbCellera Biologics Stock Jumps 15% to New 52-Week High on Hot Flash Drug Momentum and Price Target Hike

International Business Times AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy?

BlockonomiOriginal source
🌍discoverynews.google.comTier 2 · Trade media

J&J’s Imaavy secures expanded US approval in rare blood disorder

Pharmaceutical TechnologyOriginal source
🇧🇷Regulatoryinterfarma.org.brTier 1 · Regulatory source

Interfarma na imprensa: Saúde Insider publica entrevista exclusiva com Renato Porto

Interfarma BrazilOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Formulation as a key differentiator in crowded therapeutic areas

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

University of Washington and Seattle biotech win $245M patent judgment against Guardant

GeekWireOriginal source
🇺🇸CROmedidata.comTier 2 · Direct publisher

Why Research Matters: When It’s PersonalBy Tina Mincher

Medidata SolutionsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms

Good News NetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA

NewsNationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck and Moderna announced on 19 August 2026 that a personalised mRNA cancer vaccine had succeeded in a Phase 3 trial — the first time a vaccine built from a patient's own tumour mutations has cleared that bar in the history of oncology

ScienceBlog.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

STT InfoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China Resources Pharmaceutical Group (SEHK:3320) Stock Trades Cheap As Margin Recovery Seeks Credibility

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

BenzingaOriginal source